1992
DOI: 10.1097/00004850-199207020-00008
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of light treatment with citalopram in winter depression: a longitudinal single case study*

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

1994
1994
2016
2016

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 0 publications
0
11
0
Order By: Relevance
“…Whether for mood (23,28,75) or circadian disorders (26), light has been shown to be an effective and safe, yet challenging therapy. Multiple modulations have been suggested for the chromaticity (76-78), intensity (79), and pattern (55, 80) of light exposures to render them optimal for clinical and personal use.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Whether for mood (23,28,75) or circadian disorders (26), light has been shown to be an effective and safe, yet challenging therapy. Multiple modulations have been suggested for the chromaticity (76-78), intensity (79), and pattern (55, 80) of light exposures to render them optimal for clinical and personal use.…”
Section: Discussionmentioning
confidence: 99%
“…Axons emerging from the ipRGCs project to nonimage-forming (NIF) centers in the mammalian brain to evoke subcortical changes that include, but are not limited to, the resetting of circadian timing (1,10,11,16,17), suppression of melatonin production (18), activation of the pupillary light reflex (14,15), change in arousal levels (19,20) and sleep drive (21), alleviation of seasonal depression (22,23), and possibly the induction of migraine headaches (24). Given its NIF implications, light has been used for its considerable therapeutic potential in chronobiological disorders such as jet lag and shift work but has also been used to treat sleep and mood disorders as well as cognitive impairment via correction of circadian misalignment and an acute activating response (22,23,(25)(26)(27)(28)(29)(30)(31)(32).…”
Section: Introductionmentioning
confidence: 99%
“…To evaluate the responses of the circadian system to changes in light intensity, daily rhythms in locomotor activity were analyzed in animals housed in BLD or DLD, respectively. In addition to the circadian mechanisms, the monoaminergic system has also been implicated in the etiology of SAD [18], [19], [20]. To explore the neural substrates underlying the behavioral changes, the serotoninergic signals were examined in the dorsal raphe nucleus (DRN) and several other brain regions.…”
Section: Introductionmentioning
confidence: 99%
“…Moclobemide 4 weeks 5 Marked and uniform improvement, very few side effects [77] Wirz-Justice et al (1992) Citalopram Citalopram in comparison with BLT 1 Both treatments were effective [78] Heßelmann [80] Clinical trials with active comparator Martinez et al (1994) Hypericum + dim-light versus hypericum + BLT 4 weeks 20 No significant between-group differences [57] Partonen and Lonnqvist (1996) Moclobemide versus fluoxetine 6 weeks 32 No significant between-group differences [55] Ghadirian et al (1998) Tryptophan versus BLT Crossover design: 2 weeks BLT, 4 weeks tryptophan 13 Equal efficacy of tryptophan and BLT, slower relapse after withdrawal of tryptophan [81] Ruhrmann vitality in the subjects with s-SAD compared with placebo. As pathophysiological research has demonstrated a melatonergic dysregulation in SAD patients, it seems to be an interesting target for antidepressant treatment: agomelatine is the prototype of a new class of antidepressants and acts as an agonist at melatonin-1 and -2 binding sites and has antagonistic properties at the 5-HT 2C receptor.…”
Section: Open Studies and Case Reportsmentioning
confidence: 99%